Jessica Jarosz Bowman is a Wyomissing, Pennsylvania based female rheumatologist who is specialized in Rheumatology. Active license number of Jessica Jarosz Bowman for Rheumatology is MA052470 in Pennsylvania. Jessica Jarosz Bowman treat joint disease similar to orthopedists but do not perform surgeries. She diagnose and treat diseases of joints, muscle, bones and tendons which includes arthritis, back pain, muscle strains, common athletic injuries and 'collagen' diseases.
Complete Profile:
Jessica Jarosz Bowman speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
Rheumatology
Credentials:
PA C
Gender:
Female
Practice Address:
2760 Century Blvd, Wyomissing, Pennsylvania, 19610-3359
Phone:
610-375-4251
Fax:
610-685-2870
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1821073024
NPI Enumeration Date:
09 Dec, 2005
NPI Last Update On:
28 Dec, 2021
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Jessica Jarosz Bowman are as mentioned below.
License Number
Specialization
State
Status
MA052470
Rheumatologist
Pennsylvania
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
2760 Century Blvd, Wyomissing, Pennsylvania
Zip:
19610-3359
Phone Number:
610-375-4251
Fax Number:
610-685-2870
Patients can reach Jessica Jarosz Bowman at 2760 Century Blvd, Wyomissing, Pennsylvania or can call to book an appointment on 610-375-4251. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.